Tinospora cordifolia ameliorates urotoxic effect of cyclophosphamide by modulating GSH and cytokine levels

Experimental and Toxicologic Pathology

Volumn 64, Issue 4, 2012, Pages 307-314

  Hamsa, T P ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Cyclophosphamide; GSH; Pro inflammatory cytokine; Tinospora cordifolia; Urotoxicity

Indexed keywords

ALCOHOL; CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 2; PROTEIN; TINOSPORA CORDIFOLIA EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER INJURY; CONTROLLED STUDY; CYSTITIS; HISTOPATHOLOGY; LIVER WEIGHT; MALE; MENISPERMACEAE; MOUSE; NECROSIS; NONHUMAN; ORGAN WEIGHT; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SWISS WEBSTER MOUSE; TINOSPORA CORDIFOLIA; TOXICITY; UREA NITROGEN BLOOD LEVEL; UROPROTECTION; UROTOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; CYCLOPHOSPHAMIDE; CYTOKINES; DRUG ANTAGONISM; GLUTATHIONE; MALE; MICE; NECROSIS; ORGAN SIZE; PLANT EXTRACTS; TINOSPORA; URINARY BLADDER; URINARY BLADDER DISEASES;

ANIMALIA; MENISPERMACEAE; MUS; TINOSPORA CORDIFOLIA;

EID: 84859421564     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.09.003     Document Type: Article

References (59)

1. Abd-Allah A.R., Gado A.M., Al-Majed A.A., Al-Yahya A.A., Al- Shabanah O.A. Protective effect of taurine against cyclophosphamide-induced urinary bladder toxicity in rats. Clin Exp Pharmacol Physiol 2005, 32:167-172.
2. Amudha G., Josephine A., Sudhahar V., Varalakshmi P. Protective effect of lipoic acid on oxidative and peroxidative damage in cyclosporine A-induced renal toxicity. Int Immunopharmacol 2007, 7(11):1442-1449.
3. Anderson M.E. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 1998, 111-112:1-14.
4. Berlin L., MuHugh S.L. Physician's drug handbook 1999, Spring House, Spring House, Pa. 8th ed.
5. Bhatia K., Kaur M., Atif F., Ali M., Rehman H., Rahman S., et al. Aqueous extract of Trigonella foenum-graecum L. ameliorates additive urotoxicity of buthionine sulfoximine and cyclophosphamide in mice. Food Chem Toxicol 2006, 44:1744-1750.
6. Bhattacharya S.K. A handbook of medicinal plants 2001, Pointer Publications, Jaipur, India, p. 352.
7. Bin-Hafeez B., Haque R., Parvez S., Pandey S., Sayeed I., Raisuddin S. Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. Int Immunopharmacol 2003, 3:257-265.
8. Chauhan K. Successful treatment of throat cancer with ayurvedic drugs. Suchitra Ayurved 1995, 47:840-842.
9. Chung F.L., Schwartz J., Herzog C.R., Yang Y.M. Tea and cancer prevention: studies in animals and humans. J Nutr 2003, 133:3268-3274.
10. Davis L., Kuttan G. Effect of Withania somnifera on cyclophosphamide-induced urotoxicity. Cancer Lett 2000, 148:9-17.
11. 2- and cyclophosphamide-induced DNA damage. Mutagen 1999, 14:107-112.
12. DeLeve L.D., Wang X., Kuhlenkamp J.F., Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996, 23(3):589-599.
13. Donald R., Wybenga Giorgio J.D., Pileggi V.J. Manual and automated methods for urea nitrogen measurement in whole serum. Clin Chem 1971, 17:891.
14. Donnerstag B., Ohlenschlager B., Cinatle J. Reduced glutathione and S-acetylglutathione as selective apoptosis-inducing agents in cancer therapy. Cancer Lett 1996, 110:63-70.
15. Dumontet C., Drai J., Thieblemont C., Hequet O., Espinouse D., Bouafia F., et al. The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide. Br J Haematol 2001, 112:405-409.
16. Egido J.M., Gomez-Chiarri A., Ortiz C., Bustos J., Alonso C., et al. Role of tumor necrosisfactor-a in the pathogenesis of glomerular diseases. Kidney Int 1993, 39:S59-S64.
17. Erickson D.R., Tomaszewski J.E., Kunselman A.R., et al. Do the national institute of diabetes and digestive and kidney diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?. J Urol 2005, 173:93-97.
18. Fleming R.E. An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy 1997, 17:1465-1545.
19. Glaspy J.A. The potential for anemia treatment to improve survival in cancer patients. Oncology 2002, 16:35-40.
20. Hader J.E., Marzella L., Myers R.A., Jacobs S.C., Naslund M.J. Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis. J Urol 1993, 149:1617-1621.
21. Halliwell B., Gutteridge J.M.C. Protection oxygen radicals in biological system & free radical in biology and medicine. 1995, Clamendon publishers, Oxford.
22. Haque R., Bin-Hafeez B., Parvez S., Pandey S., Sayeed I., Ali M., et al. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 2003, 22:473-480.
23. Hatono S., Jimenez A., Wargovich M.J. Chemopreventive effect of S-allylcysteine and its relationship to the detoxication enzyme glutathione S-transferase. Carcinogen 1996, 17:1041-1044.
24. Hosseinimehr S.J., Karami M. Chemoprotective effects of captopril against cyclophosphamide induced genotoxicity in mouse bone marrow cells. Arch Toxicol 2005, 79:482-486.
25. Kapura P., Pereiraa B.M.J., Wattle W., Jarry H. Androgenic action of Tinospora cordifolia ethanolic extract in prostate cancer cell line LNCaP. Phytomedicine 2009, 16:679-682.
26. Kehrer J.P., Biswal S.S. The molecular effects of acrolein. Toxicol Sci 2000, 57:6-15.
27. Kerbusch T., de Kraker J., Keizer H.J., van Putten J.W., Groen H.J., Jansen R.L. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites. Clin Pharmacokin 2001, 40:41-62.
28. Kiuchi H., Takao T., Yamamoto K., Nakayama J., Miyagawa Y., Tsujimura A., et al. Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder over activity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation. J Urol 2009, 181(5):2339-2348.
29. Korkmaz A., Topal T., Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 2007, 23:303-312.
30. Lawson M., Vasilaras A., De Vries A., Mactaggart P., Nicol D. Urological implications of cyclophosphamide and ifosfamide. Scand J Urol Nephrol 2008, 42(4):309-317.
31. Lopez S.G., Luderer U. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Free Radic Biol Med 2004, 36:1366-1377.
32. Manesh C., Kuttan G. Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine 2005, 12:487-493.
33. Markus L., Jorg A.K., Ralph A.R. Immunostimulatory effects of low dose cyclophosphamide are controlled by inducible nitric oxide synthase. Cancer Res 2005, 12:5027-5030.
34. Masella R., Vari R., D'Archivio M., Benedetto R., Matarrese P., Malorni W., et al. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr 2004, 134:785-791.
35. Matsuoka Y., Masuda H., Yokoyama M., Kihara K. Protective Effects of bilirubin against cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 2008, 179:1160-1166.
36. Mazur L., Augustynek A., Bochenek M. Flow cytometric estimation of the plasma membrane diversity of bone marrow cells in mice treated with WR-2721 and cyclophosphamide. Toxicology 2002, 171:63-72.
37. Morandi P., Ruffini P.A., Benvenuto G.M., Raimondi R., Fosser V. Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transplant 2005, 35:323-334.
38. Moron M.S., Depserre J.W., Manner Vik B. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979, 82(1):67-68.
39. Oppenheim J.J. Cytokines: past, present, and future. Int J Hematol 2001, 74:3-8.
40. Ozcan A., Korkmaz A., Oter S., Coskun O. Contribution of flavonoid antioxidants to the preventive effect of MESNA in cyclophosphamide-induced cystitis in rats. Arch Toxicol 2005, 79:461-465.
41. Panchabhai T.S., Kulkarni U.P., Rege N.N. Validation of therapeutic claims of Tinospora cordifolia. Phytother Res 2008, 22:425-441.
42. Papaldo P., Lopez M., Marolla P., Cortesi E., Antimi M., Terzoli E., et al. Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. J Clin Oncol 2005, 23(28):6908-6918.
43. Perini P., Calabrese M., Rinaldi L., Gallo P. The safety profile of cyclophosphamide in multiple sclerosis therapy. Expert Opin Drug Saf 2007, 6:183-190.
44. Prince P.S., Menon V.P. Antioxidant action of Tinospora cordifolia root extract in alloxan diabetic rats. Phytother Res 2001, 5(3):213-218.
45. Rao S.K., Rao S.P., Rao N.B. Preliminary investigation of the radiosensitizing activity of Guduchi (Tinospora cordifolia) in tumor bearing mice. Phytother Res 2008, 22:1482-1489.
46. Roberts J.C., Francetic D.J., Zera R.T. Chemoprotection against cyclophosphamide-induced urotoxicity: comparison of nine thiol protective agents. Anticancer Res 1994, 14:389-395.
47. Sadir S., Deveci S., Korkmaz A., Oter S. Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage to bladder tissue in rats. Cell Biochem Funct 2007, 25:521-526.
48. Schwartz J., Domchek S.M., Hwang W.T., Fox K. Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancer. Ann Oncol 2005, 16:247-252.
49. Sheeja K., Kuttan G. Protective effect of Andrographis paniculata and andrographolide on cyclophosphamide-induced urothelial toxicity. Integr Cancer Ther 2006, 5(3):244-251.
50. Singh S.S., Pandey S.C., Srivastava S., Gupta V.S., Patro B., Ghosh A.C. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J Pharmacol 2003, 35:83-91.
51. Spelman K., Burns K., Nichols D., Winters N., Ottersberg S., Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Alt Med Rev 2006, 11(2):128-150.
52. Sulkowska M., Sulkowski S., Skrzydlewska E., Farbiszewski R. Cyclophosphamide-induced generation of reactive oxygen species. Comparison with morphological changes in type II alveolar epithelial cells and lung capillaries. Exp Toxicol Pathol 1998, 50:209-220.
53. Terlikowski S.J. Tumour necrosis factor and cancer treatment: a historical review and perspectives. Rocz Akad Med Bialymst 2001, 46:5-18.
54. Verley H. Practical clinical Biochemistry 1980, William Hieneman Medical Books Ltd., London, pp. 550-5. 5th ed.
55. Vielhauer V., Mayadas T.N. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 2007, 27(3):286-308.
56. Woodland C., Ito S., Granvil C.P., Wainer I.W., Klein J., Koren G. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sci 2000, 68:109-117.
57. Young A.S., Cummins J.M. The history of interferon and its use in animal therapy. East Afr Med J 1990, 67:31-63.
58. Zhang Q.H., Wu C.F., Duan L., Yang J.Y. Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse bone marrow cells and peripheral lymphocyte cells. Food Chem Toxicol 2008, 46:293-302.
59. Cagler K., Kinalp C., Arpaci F., Turan M., Saglam K., Ozturk B., et al. Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation. Nephrol Dial Transplant 2002, 17:1931-1935.